Test ID OLIG Oligoclonal Banding, Serum and Spinal Fluid
Specimen Required
Both serum and spinal fluid are required. Spinal fluid must be obtained within 7 days of serum collection.
Specimen Type: Serum
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Centrifuge and aliquot serum into a plastic vial within 2 hours of collection.
2. Label specimen as serum.
Specimen Type: Spinal fluid
Container/Tube: Sterile vial
Specimen Volume: 0.5 mL
Collection Instructions: Label specimen as spinal fluid.
Secondary ID
8017Useful For
Diagnosis of multiple sclerosis; especially useful in patients with equivocal clinical presentation and radiological findings
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
OLIGS | Serum Bands | No | Yes |
OLIGC | CSF Bands | No | Yes |
Method Name
Isoelectric Focusing (IEF) with IgG Immunoblot Detection
Reporting Name
Oligoclonal BandingSpecimen Type
CSFSerum
Specimen Minimum Volume
Serum, Spinal Fluid: 0.4 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
CSF | Refrigerated (preferred) | 14 days |
Ambient | 14 days | |
Frozen | 14 days | |
Serum | Refrigerated (preferred) | 14 days |
Ambient | 14 days | |
Frozen | 14 days |
Clinical Information
The diagnosis of multiple sclerosis (MS) is dependent on clinical, radiological, and laboratory findings. The detection of increased intrathecal immunoglobulin synthesis is the basis for current diagnostic laboratory tests for MS. These tests include the measurement of kappa free light chains in cerebrospinal fluid (CSF) and CSF oligoclonal band (OCB) detection. Abnormal CSF OCB patterns have been reported in 70% to 80% of MS patients.
Increased intrathecal Ig synthesis may occur in other inflammatory CSF diseases and, therefore this assay is not specific for MS.
Reference Values
CSF Oligoclonal Bands Interpretation: <2 bands
Cautions
This test is not specific for multiple sclerosis.
Day(s) Performed
Monday through Friday
Report Available
2 to 4 daysPerforming Laboratory

Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
83916 x 2